Objectives: Mutations in KCNJ11 are the most common cause of permanent neonatal diabetes mellitus (NDM). Approximately 25% of patients have obvious neurological dysfunction, but whether milder related problems might be more common has been unclear. We sought to assess the prevalence of parental concerns about learning, behavior, attention deficit hyperactivity disorder (ADHD), social competency, and sleep in subjects with KCNJ11-related NDM compared to unaffected sibling controls.
| INTRODUCTION
Neonatal diabetes mellitus (NDM), a genetic disorder characterized by the development of diabetes mellitus in the first 6 months of life, has been estimated in European populations to occur in 1 in 90 000-260 000 live births. 1, 2 Mutations in the KCNJ11 gene, encoding the Kir6.2 subunit of the ATP-sensitive potassium (K ATP ) channel, account for about 30% of cases of permanent NDM. 3, 4 Most patients with KCNJ11-related NDM can be treated with oral sulfonylureas rather than insulin injections. 5 K ATP channels are found in the hippocampus, cerebral cortex, basal ganglia and cerebellum, 6, 7 which is thought to explain the neurological dysfunction seen in some patients with KCNJ11-related NDM. 8 Approximately 25% of patients with a gene mutation of the K ATP channel subunit have clearly identifiable neurological dysfunction:
developmental delay, epilepsy and neonatal diabetes (DEND) is a discrete syndrome describing the most severe clinical form of permanent NDM; intermediate DEND (iDEND) is a less severe phenotype without epilepsy. 9 Although the remaining 75% of cases have often been described as having diabetes in isolation, some reports have suggested that these cases may have milder impairment in the form of difficulties such as learning disorders and ADHD. 10 14 Using targeted parent/guardian questionnaires and a comprehensive health survey, subjects were assessed for learning and social abilities, behavior and attention problems, attention deficit hyperactivity disorder (ADHD) and sleep disturbances (Table S1 Supporting Information). Surveys were distributed via email and in person to subjects or their guardians. All subjects with KCNJ11-related NDM were receiving treatment with sulfonylurea medications.
The unique survey created for this study included the most relevant items from the Child Behavior Checklist (CBCL). The CBCL is a standardized form to assess behavior in children, as reported by parents and parent-surrogates. The reliability and validity of the CBCL has been demonstrated through a large body of research in both clinical and non-clinical populations. 15 Our survey utilized questions from the CBCL regarding social development and learning as well as additional questions assessing behavior, sleep, ADHD and medical and therapeutic services utilized by the subjects (Table S1 ).
Data were analyzed using GraphPad Prism 6 (GraphPad Software Inc, California http://www.graphpad.com). Nonparametric analysis was performed using Fisher's exact test for group comparisons, or the two-sample t-test when variables were normally distributed. Statistical significance was considered at P < 0.05. were similar by all characteristics, including household income and age at assessment (Table 1 ).
Compared to their sibling controls, individuals with KCNJ11 mutations had significant differences in academic achievement and the need for an Individualized Education Plan (IEP), more behavior problems (P < 0.001), more symptoms and diagnoses of ADHD (P < 0.001) and higher rates of sleep difficulties (P < 0.01), per survey report (Table 2 ). When academic performance was considered com- 
| DISCUSSION
While childhood diabetes can be associated with cognitive dysfunction, it is mild in most cases and rarely meets criteria for clinically significant impairment. 16 Using a straightforward screening questionnaire, our study demonstrates that KCNJ11-related NDM may be associated with Other 7 11 a All P values were >0.05 for all comparisons between PNDM proband responders vs non-responders.
b P values were >0.05 for proband responders vs control responders, and also for the total group of responder subjects (n = 30) vs control responders.
c Based on postal code; P > 0.05 (two-sample t-test). is unknown whether they are also less likely to be facing neurodevelopmental struggles. It may therefore be possible that they were less motivated to respond to the survey addressing these concerns; however, the number of subjects with a transient history was low (six probands) and detailed testing of larger numbers of subjects are needed to determine the extent to which those with transient mild mutations exhibit any degree of neurodevelopmental impairment.
Academic difficulties associated with KCNJ11-related NDM occurred in the domains of reading, math, English and science. Compared to their unaffected siblings, more than 40% of the patients with NDM were below average in their academic achievement in these subjects, per parent report. Of these patients, 56% displayed poor handwriting skills, which may be a reflection of visual-motor deficits. 11 This is supported by the finding of poor hand-eye coordination associated with KCNJ11-related NDM. 18, 19 Parents reported behavior difficulties, lack of friendships and deficits in social awareness in their children with KCNJ11-related NDM far more often than in their unaffected children. Such challenges in social-emotional and regulatory behaviors have not been previously described with KCNJ11-related NDM, which underscores the importance of early neuropsychological assessment and continued monitoring in these patients.
In a previous study, attention deficits were found in 100% of those with KCNJ11 mutations when given in-depth neuropsychological assessments. 11 Despite the high prevalence of symptoms and diagnosis of ADHD in our cohort of patients with NDM, only three quarters of these patients were receiving any kind of treatment for ADHD. This is concerning because untreated ADHD symptoms often lead to functional impairments in multiple domains. Self-esteem, social function and academic outcomes have all been shown to improve with treatment of ADHD. 20 As patients with KCNJ11-related NDM are already at risk for having functional impairments in learning, behaviors and socialization, proper vigilance is important to recognize and treat ADHD early. The discrepancy of identifying ADHD by indepth assessment 11 vs parent report indicates the importance of neuropsychological monitoring in this at-risk population.
As has been seen in other studies of individuals with neurodevelopmental disabilities, sleep difficulties were more common among those children with a KCNJ11 mutation in our study. 12 Although no other studies have looked at the impact of KCNJ11-related NDM on sleep, it may be that impairment of K ATP channel function in the brain impacts sleep similarly to learning and behavior.
Neurodevelopmental concerns likely result from a direct effect of brain expression of mutated K ATP channels in these patients, but other factors may contribute. Diabetic ketoacidosis, seizures and episodes of severe hypoglycemia early in life-a time of critical brain development-may also impact neuropsychological and developmental progress. Pearson et al found that most transitions from insulin to sulfonylureas are safe and highly effective in the short term for most patients with KCNJ11 mutations. 3 In addition to potential neurodevelopmental improvements from sulfonylurea treatment, lifestyle changes could also significantly impact patients and their families.
Management of NDM with sulfonylurea medications results in less frequent blood sugar monitoring and improved glycemic control, and a likely lower risk of short term and long-term complications. Furthermore, initiation of sulfonylurea therapy at a younger age allows for lower doses of medication and less need for additional medications.
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Modest improvements in cognitive and motor functioning occur in some affected patients after transition from insulin injection to oral sulfonylureas. 9, 22 Slingerland et al found that transition from insulin to sulfonylureas positively impacted motor and cognitive function even in patients who were older than the time of critical brain development, 9 but the timing of medication transition may influence the degree of benefit possible and may also significantly influence social-emotional and regulatory behaviors. In this regard, our previous study suggested that visuomotor performance can be improved by early treatment (under one year of age) with sulfonylureas in patients with KCNJ11-related NDM. 18 Results of the current study demon-should look at using a control group of individuals with other mutations that cause NDM in isolation, such as insulin gene mutations.
The group of patients with KCNJ11-related NDM is difficult to compare to other individuals with diabetes, owing to the fact that they are treated with oral sulfonylureas rather than insulin and they do not regularly check their blood sugar.
Patients with KCNJ11-related NDM are at an increased risk for delays in learning, social-emotional and behavioral development. 
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